Companies

FATE THERAPEUTICS INC (FATE) SEC filings

CIK 0001434316 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)6.6 M63.5 M96.3 M
Net income (USD)-281.7 M-212.2 M
Diluted EPS (USD/shares)-1.15-1.64-2.91

Latest filings

FiledFormDescriptionPeriod
2026-09-288-K8-K items 8.01,9.012026-09-25
2026-08-13S-8S-8
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-08-05442026-08-04
2026-08-05442026-08-04
2026-08-04144144
2026-08-04144144
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-154OWNERSHIP DOCUMENT2026-06-12
2026-06-154OWNERSHIP DOCUMENT2026-06-12
2026-06-15442026-06-12
2026-06-15442026-06-12
2026-06-15442026-06-12
2026-06-15442026-06-12
2026-06-15442026-06-12
2026-06-15442026-06-12
2026-06-15442026-06-12
2026-06-15332026-06-12
2026-06-158-K8-K items 5.02,5.07,9.012026-06-12
2026-06-048-K8-K items 8.01,9.012026-06-04
2026-05-21442026-05-20
2026-05-21442026-05-20
2026-05-20144144
2026-05-20144144

Forms on file (last 1,000): 4 357, 8-K 132, SC 13G/A 44, 10-Q 39, 3 37, 144 31, S-8 17, SC 13G 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=FATE (0.002 USD), /gw/filings/filings?ticker=FATE&form=8-K, /gw/filings/facts?ticker=FATE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange